Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology

NeuroImage: Clinical

Volumn 4, Issue , 2014, Pages 508-516

  Laforce Jr , Robert ^a,b,c   Tosun, Duygu ^b   Ghosh, Pia ^a,b   Lehmann, Manja ^a,b   Madison, Cindee M ^a   Weiner, Michael W ^b   Miller, Bruce L ^b   Jagust, William J ^a   Rabinovici, Gil D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Amyloid imaging; FDG PET; Functional connectivity; Multivariate data analysis; Networks; Parallel ICA; PiB PET

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; FLUORODEOXYGLUCOSE F 18; PITTSBURGH COMPOUND B; BENZOTHIAZOLE DERIVATIVE; BIOLOGICAL MARKER; GLUCOSE; N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CUNEUS; DEFAULT MODE NETWORK; EDUCATIONAL STATUS; FEMALE; GLUCOSE METABOLISM; HUMAN; IMAGE PROCESSING; INDEPENDENT COMPONENT ANALYSIS; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL LOBE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; POSTERIOR PARIETAL CORTEX; PRECUNEUS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TEMPORAL LOBE; VISUAL MEMORY; BRAIN; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; MULTIMODAL IMAGING; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; AMNESIA; AREA UNDER THE CURVE; LANGUAGE; MEMORY; RECEIVER OPERATING CHARACTERISTIC;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BENZOTHIAZOLES; BIOMARKERS; BRAIN; DATA INTERPRETATION, STATISTICAL; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84897016664     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2014.03.005     Document Type: Article

References (55)

1. Bourgeat, P., Chételat, G., Villemagne, V.L., Fripp, J., Raniga, P., Pike, K., et al. 2010. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 74 (2), 121-7. http://dx.doi.org/10.1212/WNL.0b013e3181c918b5, 20065247 .
2. Brickman, A.M., Habeck, C., Zarahn, E., Flynn, J., Stern, Y., 2007. Structural MRI covariance patterns associated with normal aging and neuropsychological functioning. Neurobiology of Aging 28 (2), 284-95. http://dx.doi.org/10.1016/j.neurobiolaging.2005.12.016, 16469419.
3. Calhoun, V.D., Adali, T., Kiehl, K.A., Astur, R., Pekar, J.J., Pearlson, G.D., 2006. A method for multitask fMRI data fusion applied to schizophrenia. Human Brain Mapping 27 (7), 598-610. http://dx.doi.org/10.1002/hbm.20204, 16342150.
4. Cohen, A.D., Price, J.C., Weissfeld, L.A., James, J., Rosario, B.L., Bi, W., et al. 2009. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29 (47), 14770-8. http://dx.doi.org/10.1523/JNEUROSCI.3669-09.2009, 19940172.
5. de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D.H., Kopeikina, K.J., et al. 2012. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73 (4), 685-97. http://dx.doi.org/ 10.1016/j.neuron.2011.11.033,22365544.
6. de Souza, L.C., Corlier, F., Habert, M.O., Uspenskaya, O., Maroy, R., Lamari, F., et al. 2011. Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease. Brain: a Journal of Neurology 134 (7), 2036-43. http://dx.doi.org/10.1093/brain/awr130, 21705422.
7. Devanand, D.P., Habeck, C.G., Tabert, M.H., Scarmeas, N., Pelton, G.H., Moeller, J.R., et al. 2006. PET network abnormalities and cognitive decline in patients with mild cognitive impairment. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 31 (6), 1327-34, 16292330.
8. Dubois, B., Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P., Cummings, J., et al. 2007. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurology 6 (8), 734-46. http://dx.doi.org/10.1016/S1474- 4422(07)70178-3, 17616482.
9. Edison, P., Archer, H.A., Hinz, R., Hammers, A., Pavese, N., Tai, Y.F., et al. 2007. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [ 11 C]PIB and [ 18 F]FDG PET study. Neurology 68 (7), 501-8. http://dx.doi.org/ 10.1212/01.wnl.0000244749.20056.d4, 17065593.
10. Eidelberg, D., Dhawan, V., Moeller, J.R., Sidtis, J.J., Ginos, J.Z., Strother, S.C., et al. 1991. The metabolic landscape of corticobasal ganglionic degeneration: regional asymmetries studied with positron emission tomography. Journal of Neurology, Neuro-surgery, and Psychiatry 54 (10), 856-62. http://dx.doi.org/10.1136/jnnp.54.10.856, 1744638.
11. Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., et al. 2006. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain: a Journal of Neurology 129 (11), 2856-66. http://dx.doi.org/10.1093/brain/awl178, 16854944.
12. Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychi-atric Research 12 (3), 189-98. http://dx.doi.org/10.1016/0022- 3956(75)90026-6,1202204.
13. Furst, A.J., Rabinovici, G.D., Rostomian, A.H., Steed, T., Alkalay, A., Racine, C., et al. 2012. Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiology of Aging 33 (2), 215-25. http://dx.doi.org/10. 1016/j.neurobiolaging.2010.03.011, 20417582.
14. Gorno-Tempini, M.L., Dronkers, N.F., Rankin, K.P., Ogar, J.M., Phengrasamy, L., Rosen, H.J., et al. 2004. Cognition and anatomy in three variants of primary progressive aphasia. Annals of Neurology 55 (3), 335-46. http://dx.doi.org/10.1002/ana.10825, 14991811.
15. Gorno-Tempini, M.L., Hillis, A.E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S.F., et al. 2011. Classification of primary progressive aphasia and its variants. Neurology 76 (11), 1006-14. http://dx.doi.org/10.1212/WNL. 0b013e31821103e6, 21325651.
16. Habeck, C., Foster, N.L., Perneczky, R., Kurz, A., Alexopoulos, P., Koeppe, R.A., et al. 2008. Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. NeuroImage 40 (4), 1503-15. http://dx.doi.org/10.1016/j. neuroimage.2008.01.056, 18343688.
17. Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Petersen, R.C., Weiner, M.W., Aisen, P.S., et al. 2013. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurology 12 (2), 207-16. http://dx.doi.org/10.1016/S1474- 4422(12)70291- 0, 23332364.
18. Kim, E.J., Cho, S.S., Jeong, Y., Park, K.C., Kang, S.J., Kang, E., et al. 2005. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain: a Journal of Neurology 128 (8), 1790-801. http://dx.doi.org/10.1093/brain/awh539, 15888536.
19. Kramer, J.H., Jurik, J., Sha, S.J., Rankin, K.P., Rosen, H.J., Johnson, J.K., et al. 2003. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cognitive and Behavioral Neurology: Official Journal of the Society for Behavioral and Cognitive Neurology 16 (4), 211-18. http://dx.doi.org/10.1097/00146965- 200312000-00002, 14665820.
20. La, Joie R., Perrotin, A., Barré, L., Hommet, C., Mézenge, F., Ibazizene, M., et al. 2012. Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (A β) load in Alzheimer's disease dementia. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32 (46), 16265-73. http://dx.doi.org/10.1523/JNEUROSCI.2170-12. 2012, 23152610.
21. Lehmann, M., Crutch, S.J., Ridgway, G.R., Ridha, B.H., Barnes, J., Warrington, E.K., et al. 2011. Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical. Alzheimer'S Disease. Neurobiology of Aging 32 (8), 1466-76. http://dx.doi.org/10.1016/j.neurobiolaging.2009.08.017.
22. Lehmann, M., Barnes, J., Ridgway, G.R., Ryan, N.S., Warrington, E.K., Crutch, S.J., et al. 2012. Global gray matter changes in posterior cortical atrophy: a serial imaging study. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 8, 502-12. http://dx.doi.org/10.1016/j.jalz.2011.09. 22510.1016/j.jalz.2012.05, 22365384.
23. Lehmann, M., Ghosh, P.M., Madison, C., Laforce, R. Jr., Corbetta-Rastelli, C., Weiner, M.W., et al. 2013. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain: a Journal of Neurology 136 (3), 844-58. http://dx.doi.org/10. 1093/brain/aws327, 23358601.
24. Lehmann, M., Madison, C.M., Ghosh, P.M., Seeley, W.W., Mormino, E., Greicius, M.D., et al. 2013. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 110 (28), 11606-11. http://dx.doi.org/10.1073/pnas.1221536110, 23798398.
25. Leyton, C.E., Villemagne, V.L., Savage, S., Pike, K.E., Ballard, K.J., Piguet, O., et al. 2011. Subtypes of progressive aphasia: application of the international consensus criteria and validation using beta-amyloid imaging. Brain: a Journal of Neurology 134 (10), 3030-43. http://dx.doi.org/10.1093/ brain/awr216, 21908392.
26. Li, Y., Rinne, J.O., Mosconi, L., Pirraglia, E., Rusinek, H., DeSanti, S., et al. 2008. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. European Journal of Nuclear Medicine and Molecular imaging 35 (12), 2169-81. http://dx.doi.org/10.1007/ s00259-008-0833-y, 18566819.
27. Liu, J., Pearlson, G., Windemuth, A., Ruano, G., Perrone-Bizzozero, N.I., Calhoun, V., 2009. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Human Brain Mapping 30 (1), 241-55. http://dx.doi.org/10.1002/hbm.20508, 18072279.
28. Logan, J., Fowler, J.S., Volkow, N.D., Wang, G.J., Ding, Y.S., Alexoff, D.L., 1996. Distribution volume ratios without blood sampling from graphical analysis of PET data. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 16 (5), 834-40, 8784228.
29. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr., Kawas, C.H., et al. 2011. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 7 (3), 263-9. http://dx.doi.org/10.1016/j.jalz.2011.03.005, 21514250.
30. Migliaccio, R., Agosta, F., Rascovsky, K., Karydas, A., Bonasera, S., Rabinovici, G.D., et al. 2009. Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology 73 (19), 1571-8. http://dx.doi.org/10.1212/WNL.0b013e3181c0d427, 19901249.
31. Moeller, J.R., Eidelberg, D., 1997. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing. Brain: a Journal of Neurology 120 (12), 2197-206. http://dx.doi.org/10.1093/brain/120.12. 2197, 9448575.
32. Mormino, E.C., Brandel, M.G., Madison, C.M., Rabinovici, G.D., Marks, S., Baker, S.L., et al. 2012. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage 59 (2), 1152-60. http://dx.doi.org/10.1016/j.neuroimage. 2011.07.098, 21884802.
33. Morris, J.C., 1993. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43 (11), 2412-14. http://dx.doi.org/10.1212/WNL.43. 11.2412-a10.1212/WNL.43.11.2412, 8232972.
34. Mueller, S.G., Laxer, K.D., Barakos, J., Cheong, I., Garcia, P., Weiner, M.W., 2009. Widespread neocortical abnormalities in temporal lobe epilepsy with and without mesial sclerosis. NeuroImage 46 (2), 353-9. http://dx.doi.org/10. 1016/j.neuroimage.2009.02.020, 19249372.
35. Ng, S.Y., Villemagne, V.L., Masters, C.L., Rowe, C.C., 2007. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B. Archives of Neurology 64 (8), 1140-4. http://dx.doi.org/10.1001/archneur.64.8.1140, 17698704.
36. O'Toole, A.J., Jiang, F., Abdi, H., Pénard, N., Dunlop, J.P., Parent, M.A., 2007. Theoretical, statistical, and practical perspectives on pattern-based classification approaches to the analysis of functional neuroimaging data. Journal of Cognitive Neuroscience 19 (11), 1735-52. http://dx.doi.org/10.1162/jocn.2007.19.11.1735, 17958478.
37. Price, J.C., Klunk, W.E., Lopresti, B.J., Lu, X., Hoge, J.A., Ziolko, S.K., et al. 2005. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. Journal of Cerebral Blood Flow & Metabolism 25 (11), 1528-47. http://dx.doi.org/10.1038/sj.jcbfm.9600146, 15944649.
38. Rabinovici, G.D., Furst, A.J., Alkalay, A., Racine, C.A., O'Neil, J.P., Janabi, M., et al. 2010. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 133 (2), 512-28. http://dx.doi.org/10.1093/brain/awp326.
39. Rabinovici, G.D., Furst, A.J., O'Neil, J.P., Racine, C.A., Mormino, E.C., Baker, S.L., et al. 2007. 11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 68 (15), 1205-12. http://dx.doi.org/10.1212/01.wnl.0000259035.98480.ed, 17420404.
40. Rabinovici, G.D., Jagust, W.J., Furst, A.J., Ogar, J.M., Racine, C.A., Mormino, E.C., et al. 2008. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Annals of Neurology 64 (4), 388-401. http://dx.doi.org/10.1002/ana.21451, 18991338.
41. Rabinovici, G.D., Rosen, H.J., Alkalay, A., Kornak, J., Furst, A.J., Agarwal, N., et al. 2011. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology 77 (23), 2034-42. http://dx.doi.org/10.1212/WNL. 0b013e31823b9c5e, 22131541.
42. Rachakonda, S., Liu, J., Calhoun, V. (2008), Fusion ICA Toolbox (FIT)
43. Rosen, H.J., Gorno-Tempini, M.L., Goldman, W.P., Perry, R.J., Schuff, N., Weiner, M., et al. 2002. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58 (2), 198-208. http://dx.doi.org/10.1212/WNL. 58.2.198, 11805245.
44. Rosenbloom, M.H., Alkalay, A., Agarwal, N., Baker, S.L., O'Neil, J.P., Janabi, M., et al. 2011. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology 76 (21), 1789-96. http://dx.doi.org/10.1212/WNL.0b013e31821cccad, 21525424.
45. Scheltens, P., Erkinjunti, T., Leys, D., Wahlund, L.O., Inzitari, D., del Ser, T., et al. 1998. White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. European Neurology 39 (2), 80-9. http://dx.doi.org/10.1159/000007921, 9520068.
46. Seeley, W.W., Crawford, R.K., Zhou, J., Miller, B.L., Greicius, M.D., 2009. Neurodegenerative diseases target large-scale human brain networks. Neuron 62 (1), 42-52. http://dx.doi.org/10.1016/j.neuron.2009.03.024, 19376066.
47. Sepulcre, J., Sabuncu, M.R., Becker, A., Sperling, R., Johnson, K.A., 2013. In vivo characterization of the early states of the amyloid-beta network. Brain: a Journal of Neurology 136 (7), 2239-52. http://dx.doi.org/10.1093/brain/ awt146, 23801740.
48. Shirer, W.R., Ryali, S., Rykhlevskaia, E., Menon, V., Greicius, M.D., 2012. Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cerebral Cortex (New York, N.Y.: 1991) 22 (1), 158-65. http://dx.doi.org/10.1093/cercor/bhr099, 21616982.
49. Smith, S.M., Fox, P.T., Miller, K.L., Glahn, D.C., Fox, P.M., Mackay, C.E., et al. 2009. Correspondence of the brain's functional architecture during activation and rest. Proceedings of the National Academy of Sciences of the United States of America 106, 13040-5. http://dx.doi.org/10.1073/pnas. 0905267106, 19620724.
50. Tang-Wai, D.F., Graff-Radford, N.R., Boeve, B.F., Dickson, D.W., Parisi, J.E., Crook, R., et al. 2004. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 63 (7), 1168-74. http://dx.doi.org/10.1212/01.WNL.0000140289.18472.15, 15477533.
51. Thomas, B.A., Erlandsson, K., Modat, M., Thurfjell, L., Vandenberghe, R., Ourselin, S., et al. 2011. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular imaging 38 (6), 1104-19. http://dx.doi.org/10. 1007/s00259- 011- 1745-9, 21336694.
52. Tosun, D., Schuff, N., Mathis, C.A., Jagust, W., Weiner, M.W., 2011. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain: a Journal of Neurology 134 (4), 1077-88. http://dx.doi.org/10.1093/brain/awr044, 21429865.
53. Whitwell, J.L., Jack, C.R. Jr., Kantarci, K., Weigand, S.D., Boeve, B.F., Knopman, D.S., et al. 2007. Imaging correlates of posterior cortical atrophy. Neurobiology of Aging 28 (7), 1051-61. http://dx.doi.org/10.1016/j. neurobiolaging.2006.05.026, 16797786.
54. Zhang, S., Li, C.S., 2012. Functional connectivity mapping of the human precuneus by resting state fMRI. Neuroimage 59 (4), 3548-62. http://dx.doi.org/10.1016/j.neuroimage.2011.11.023, 22116037.
55. Zhou, J., Gennatas, E.D., Kramer, J.H., Miller, B.L., Seeley, W.W., 2012. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron 73 (6), 1216-27. http://dx.doi.org/10.1016/j.neuron.2012.03. 004, 22445348.